vigabatrin has been researched along with Glycine Encephalopathy in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Vigabatrin, a structural analogue of gamma-aminobutyric acid (GABA), is used for the treatment of generalized and partial seizures in infants." | 3.73 | Vigabatrin caused rapidly progressive deterioration in two cases with early myoclonic encephalopathy associated with nonketotic hyperglycinemia. ( Coker, M; Gokben, S; Karapinar, B; Polat, M; Serdaroğlu, G; Tekgul, H; Tosun, A; Yurtsever, S, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tekgul, H | 1 |
| Serdaroğlu, G | 1 |
| Karapinar, B | 1 |
| Polat, M | 1 |
| Yurtsever, S | 1 |
| Tosun, A | 1 |
| Coker, M | 1 |
| Gokben, S | 1 |
1 other study available for vigabatrin and Glycine Encephalopathy
| Article | Year |
|---|---|
Vigabatrin caused rapidly progressive deterioration in two cases with early myoclonic encephalopathy associated with nonketotic hyperglycinemia.
Topics: Anticonvulsants; Disease Progression; Electroencephalography; Epilepsies, Myoclonic; Fatal Outcome; | 2006 |